Table of contents

Original Articles

• Mode of detection of recurrent gynecological malignancy: does routine follow-up delay diagnosis and treatment? (1 September, 2006)

  A. J. Nordin, The National Group Of Gynaecology Nssg Leads
• Measurement of vaginal length: reliability of the vaginal sound—a Gynecologic Oncology Group Study (1 September, 2006)

  D. W. Bruner, S. A. Nolte, M. S. Shahin, H. Q. Huang, E. Sobel, D. Gallup, D. Cella
• Ovarian cancer—can intraperitoneal therapy be regarded as new standard in Germany? (1 September, 2006)

  A. Du Bois, B. Schmalfeldt, W. Meier, J. Sehouli, J. Pfisterer, ARBEITSGEMEINSCHAFT GYNAEKOLOGISCHE ONKOLOGIE [AGO] KOMMISSION OVAR, THE AGO STUDY GROUP OVARIAN CANCER [AGO-OVAR], AND THE NORDDEUTSCHE GESELLSCHAFT FUER GYNAEKOLOGISCHE ONKOLOGIE [NOGGO]
• Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective (1 September, 2006)

  M. Alhayki, L. Hopkins, T. Le, M. FUNG KEE Fung
• Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: a university teaching hospital experience (1 September, 2006)

  C. A. Leath, J. E. Kendrick, T. M. Numnum, J. M. Straughn, R. P. Rocconi, G. P. Sfakianos, J. D. Lang
• Survival in ovarian cancer in Wales: prior to introduction of all Wales guidelines (1 September, 2006)

  T. S. Shylasree, R. E.J. Howells, K. Lim, P. W. Jones, A. Fiander, M. Adams, A. S. Evans, THE ALL WALES GYNAECOLOGICAL CANCER STEERING GROUP
• Inhibition of nuclear factor-κB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line (1 September, 2006)

  G. H. Liu, S. R. Wang, B. Wang, B. H. Kong
• Expression of aminopeptidase N/CD13 in human ovarian cancers (1 September, 2006)

  P. Surowiak, M. DrĄG, V. Materna, S. Suchocki, R. Grzywa, M. SpaczyŃSki, M. Dietel, J. Oleksyszyn, M. Zabel, H. Lage
• The prognostic value of endoglin (CD105) expression in ovarian carcinoma (1 September, 2006)

  C. Taskiran, O. Erdem, A. Onan, O. Arisoy, A. Acar, C. Vural, M. Erdem, O. Ataoglu, H. Guner
• Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma (1 September, 2006)

  D. Ripley, R. Tunuguntla, L. Susi, N. Chegini
• The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study (1 September, 2006)

  C.-A. Chen, C.-Y Liu, H.-H Chou, C.-Y. Chou, C.-M Ho, N.-F. Twu, Y.-Y. Kan, M.-H. Chuang, T.-Y. Chu, C.-Y. Hsieh
• Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia (1 September, 2006)

  M. A. De Boer, J. N.I. Vet, M. F. Aziz, S. Cornain, G. Purwoto, B. E.W.M. Van Den Akker, A. Dijkman, A. A.W. Peters, G. J. Fleuren
• Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix (1 September, 2006)

  P. F. Escobar, L. Rojas-Espaillat, S. Tisci, C. Enerson, J. Brainard, J. Smith, N. J. Tresser, F. I. Feldchtein, L. B. Rojas, J. L. Belinson
• The use of electrical impedance spectroscopy in the detection of cervical intraepithelial neoplasia (1 September, 2006)

  S. Abdul, B. H. Brown, P. Milnes, J. A. Tidy
• Cervical cancer incidence and survival in Korea: 1993–2002 (1 September, 2006)

  H. H. Chung, M. J. Jang, K. W. Jung, Y. J. Won, H. R. Shin, J. W. Kim, H.-P. Lee, THE MEMBERS FOR GYNECOLOGIC ONCOLOGY COMMITTEE OF KOREAN SOCIETY OF OBSTETRICS AND GYNECOLOGY
• Pattern of failure and long-term morbidity in patients undergoing postoperative radiotherapy for cervical cancer (1 September, 2006)

  P. Jain, R. D. Hunter, J. E. Livsey, C. Coyle, H. C. Kitchener, R. Swindell, S. E. Davidson
• Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging (1 September, 2006)

  Y. S. Choi, C. M. Yi, J.-I. Sin, G. W. Ye, I. H. Shin, T. S. Lee
• Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation (1 September, 2006)

  S. M. Temkin, M. Hellmann, E. Serur, Y.-C. Lee, O. Abulafia
• Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients (1 September, 2006)

  C. C. Ren, X. H. Miao, B. Yang, L. Zhao, R. Sun, W. Q. Song
• Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis (1 September, 2006)

  Y.-X. Yang, A.-H. Yang, Z.-J. Yang, Z.-R. Wang, X.-H. Xia
• Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence (1 September, 2006)

  P.-H. Wang, J.-L. Ko
• Lymph node size in uterine cancer: a revisit (1 September, 2006)

  S. Tangjitgamol, S. Manusirivithaya, S. Jesadapatarakul, S. Leelahakorn, T. Thawaramara
• Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: an analysis of 208 patients (1 September, 2006)

  I. Kalogiannidis, S. Lambrechts, F. Amant, P. Neven, E. Van Limbergen, I. Vergote
• Uterine metastasis from hepatocellular carcinoma: a case report (1 September, 2006)

  E. Ryo, T. Sato, S. Takeshita, T. Ayabe, F. Tanaka
• HER‐2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications

  (1 September, 2006)

  J. A. Villella, S. Cohen, D. H. Smith, H. Hibshoosh, D. Hershman
• Immunohistochemical characterization of cancer antigen in uterine cancers (1 September, 2006)

  S. Nur, L. Chuang, G. Ramaswamy
• Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions (1 September, 2006)

  O. Graesslin, A. Cortez, C. Uzan, P. Birembaut, C. Quereux, E. DaraÏ
• Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors (1 September, 2006)

  A. H. El-Shalakany, K. M. Kamel, A. M. Ismail, L. Salah, S. S. El-Deen Fahmy, E. EL-DEEN Ammar